Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT00325260
Eligibility Criteria:
Inclusion Criteria:
* signed and dated informed consent
* being healthy
* mental health enough to understand the study, the informed consent form and the questionnaire
Exclusion Criteria:
* known to be allergic to constituents of the vaccine
* having an autoimmune disorder, taking immunomodulating drugs or having immune disfunction secondary to HIV
* having had a documented serious adverse reaction to previous influenza vaccination
* having had documented influenza infection or vaccination in the six months prior to the start of the study
* having received any other vaccines, immunoglobulins or investigational drugs in the month prior to the start of the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Years
Study:
NCT00325260
Study Brief:
Protocol Section:
NCT00325260